Weekly signal · RVMD · Healthcare

Revolution Medicines Inc (RVMD) holds active weekly trend after 96.2% 12-week run

The oncology biotech remains on momentum screens, though turnover is not keeping pace with the strength in price.

Revolution Medicines Inc
Latest189.24 USD
1W move3.9%
Volume0.9x
TrendActive
Weekly market chart display with biotechnology research equipment for Revolution Medicines.

Market update

What happened

Revolution Medicines Inc (RVMD) closed the latest week at 189.24 USD, up 3.9%, as the Healthcare stock continued to draw attention in weekly market data. The weekly price path over 52 weeks frames the move as longer-horizon strength, not live intraday action.

Confirmation remains firm but not one-sided. Relative Strength stands at 87.6 and Market Dynamics shows positive pressure at 1.15, while latest volume of 14.6 million shares came in below the 13-week average of 16.8 million.

Continue your research

Explore RVMD across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

RVMD coverage

Evidence context